Division of Diabetes Endocrinology and Metabolism

January 4, 2024

Study shows liraglutide results in increased insulin sensitivity independent of weight loss

By Jill Clendening
October 17, 2023

Powers announces plan to step down from key diabetes leadership roles

Alvin C. Powers, MD, has announced plans to step down effective July 1, 2024, as director of the Vanderbilt Diabetes Center, director of the Vanderbilt Diabetes Research and Training Center, and chief of the Division of Diabetes, Endocrinology and Metabolism.

By Jill Clendening
October 17, 2023

Tirzepatide trial shows additional 21.1% weight loss following intensive lifestyle intervention

A Vanderbilt clinical trial evaluating the injectable prescription medication tirzepatide, showed an additional 21.1% weight loss after intensive lifestyle intervention in adults with obesity or who were overweight with weight-related comorbidities, excluding Type 2 diabetes.

By Jill Clendening
September 12, 2023

Takkouche named associate chief medical officer for Wilson and Sumner County regions

Sahar Takkouche, MD, director of the Vanderbilt Weight Loss Center in Wilson County, has been named to the role of associate chief medical officer for Wilson and Sumner County regions.

By John Howser
July 26, 2023

Chase Hendrickson named executive medical director of the Medicine Patient Care Center

Chase Hendrickson, MD, MPH, has been named executive medical director of the Medicine Patient Care Center.

By Kathy Whitney
A Vanderbilt study shows that reducing consumption of simple sugars helped improve gastroesophageal reflux disease.
June 13, 2023

Maternal diet influences postnatal diabetes risk

Studies in a primate animal model suggest that islet hyperfunction — which in humans is associated with increased fat mass and Type 2 diabetes — is programmed in offspring by a maternal Western-style diet during pregnancy.

By Bill Snyder
March 23, 2023

Saunders receives diabetes research innovation award

Vanderbilt's Diane Saunders, PhD, has been selected as a 2023 recipient of an Innovation Award by the Network of Pancreatic Donors with Diabetes.
By Jill Clendening
September 27, 2022

Diagnostic biomarker for bone disorder

A urine chemical performs better as a diagnostic biomarker for the soft bone disease hypophosphatasia than other laboratory measures, Vanderbilt researchers have demonstrated.
By Leigh MacMillan
September 8, 2022

Diabetes research grant receives NIDDK renewal

The Vanderbilt Diabetes Research and Training Center is celebrating its 49th year of continual operation with the five-year competitive renewal of a $10.9 million grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health.
By Jill Clendening
May 24, 2022

Diabetes, cardiovascular drug targets

Targeting receptors of the inflammatory lipid signaling molecule PGE2 may offer a new way to tackle both Type 2 diabetes and cardiovascular disease, Vanderbilt researchers have discovered.
By Leigh MacMillan
March 24, 2022

Reducing obesity-related inflammation

A treatment that increases levels of lipid signaling molecules reduced adipose tissue inflammation in obese adults, suggesting this pathway may be a valuable target for modulating fat and systemic inflammation.
By VUMC News and Communications
February 21, 2022

VUMC mourns loss of dedicated clinician, teacher Fowler

Vanderbilt's Michael Fowler, MD, associate professor of Medicine in the Division of Diabetes, Endocrinology and Metabolism, a celebrated Master Clinical Teacher, and co-medical director of the Shade Tree Clinic, died Feb. 20. He was 49.
By Kathy Whitney
November 11, 2021

International gathering scrutinizes immune response, beta cell biology in Type 1 diabetes

By Jill Clendening
1 2